e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: SUN11031 (synthetic human ghrelin) improves lean body mass (LBM) and function in advanced COPD cachexia
J. M. Gertner, B. Levinson (Rochelle Park, United States Of America)
Source:
Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Session:
Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Session type:
E-Communication Session
Number:
2154
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. M. Gertner, B. Levinson (Rochelle Park, United States Of America). Late Breaking Abstract: SUN11031 (synthetic human ghrelin) improves lean body mass (LBM) and function in advanced COPD cachexia. Eur Respir J 2010; 36: Suppl. 54, 2154
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD: Different psychology status (PS) in the patients with different fat free body mass (FFBM)
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Lean body mass is positively associated with lung function at age 15
Source: International Congress 2017 – Determinants of childhood asthma and atopy
Year: 2017
Influence of body weight and fat mass on pulmonary function and performance status of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003
Low fat-free mass and body mass index are associated with worse survival in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients?
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Dyspnea and mortality in elderly: the role of the body mass index (BMI)
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Staging COPD with body mass index and fat free mass index: relations with parameters expressing disease severity
Source: Eur Respir J 2006; 28: Suppl. 50, 162s
Year: 2006
Study of body mass index and serum leptin in asthmatics
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Whole-body resting and exercise-induced lipolysis in sarcopaenic patients with COPD
Source: Eur Respir J 2008; 32: 1466-1471
Year: 2008
Lean mass predicts asthma better than fat mass among females
Source: Eur Respir J 2011; 37: 65-71
Year: 2011
Body mass index in COPD: what relationship?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Association of weight loss in COPD patients with low body mass index on outcomes
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011
The regional distribution of body fat mass (BFM) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Associations of BMI, fat mass and lean mass with childhood asthma: Mendelian randomization study
Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Year: 2013
The role of regional distribution (RD) of body fat mass (BFM) in fat-bone interactions in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Predictors of body mass index and body fat after lung and heart transplantation
Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Year: 2010
The combination of low fat-free mass and high fat mass is related to functional outcome and systemic inflammation in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Relationships between pulmonary function tests and body mass index and body composition in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005
Influence of the body mass index on the survival of COPD patients
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Does body mass index really contribute to asthma?
Source: Eur Respir J 2007; 30: Suppl. 51, 382s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept